Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia

Recruiting now

Conditions studied: CAR T-cell Therapy, Autoimmune Hemolytic Anemia, Brain Function, Psychological Well-Being

In brief

Cell therapy is an innovative treatment with significant efficacy in hematologic and certain autoimmune diseases. Although it offers potential benefits for autoimmune hemolytic anemia (AIHA), it may result in cognitive and other potential impairments, which can adversely affect patients' cognition and behavior. Brain function and psychological assessment are essential for the early detection of potential impairments, allowing timely interventions to prevent complications and ensure patient safety. This study aims to comprehensively evaluate the physical and psychological impacts of cell therapy on AIHA patients to develop safer and more effective treatment strategies that enhance their quality of life.

Key facts

Study ID

NCT06921980

Run by

Institute of Hematology & Blood Diseases Hospital, China

People needed

20

Starts

2025-02-25

Expected to finish

2026-12-31

Last updated by the study team

2025-08-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of AIHA
• Subjects will receive cell therapy such as CAR T-cell therapy
• Male or female, aged 18-65 years
• Willing and able to comply with the requirements for this study and written informed consent

You may not qualify if…

• History of psychiatric illness
• History of severe brain disease
• Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study

Where it is running

• Regenerative Medicine Center — Tianjin, Tianjin Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.